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erine protease functionality is based on nucleophilic
attack of a targeted peptidic bond by a serine. The serine
protease superfamily is extremely diverse and includes
proteases such as plasminogen, prostatin, hepsin, the
kallikrein family (KLK genes clustered on chromosome
19.13), and a recently discovered cluster of tryptic-like serine
proteases located on human chromosome 16p13.1 2 Serine
protease mutations have been reported as causative in only a
few autosomal recessive human hereditary conditions, which
produce diverse pathological conditions.3 4 We report the first
human kallikrein mutation and describe its association with
a rare autosomal recessive form of amelogenesis imperfecta.
The amelogenesis imperfectas are a clinically and geneti-
cally heterogeneous group of disorders characterised by faulty
development of the tooth enamel due to hypoplasia or
hypomineralisation.5 The amelogenesis imperfecta pheno-
types vary widely depending on the specific gene involved,
the location and type of mutation, and the corresponding
putative change at the protein level.6 7 The amelogenesis
imperfecta enamel defects can be broadly divided into
hypoplastic (enamel crystallites do not grow to the correct
length) and hypomineralised (crystallites fail to grow in
thickness or width) phenotypes. The prevalence of amelo-
genesis imperfecta varies in different countries (ranging from
1 in 700 in Sweden to 1 in 14 000 in the United States)
suggesting allele frequency differences between popula-
tions.8–11 Amelogenesis imperfecta can be inherited as an
autosomal dominant, autosomal recessive, or X-linked
Mendelian trait. While autosomal dominant amelogenesis
imperfecta types are most common in the United States and
Europe, autosomal recessive amelogenesis imperfecta types
are more common in the Middle East.8 10 11
Dental enamel is the most highly mineralised tissue in the
human body with 85% of its volume occupied by highly
organised carbonate substituted hydroxyapatite crystals.12
These crystallites are packed into a highly ordered decussat-
ing prism pattern giving enamel many of its unique wear and
fracture resistant properties. Development of the unique
enamel mineral structure and composition is rigorously
controlled by the ameloblasts through their secretion of a
unique extracellular matrix that is processed in a highly
controlled manner. Enamel formation requires the expression
of multiple genes that transcribe matrix proteins and pro-
teinases necessary to control the exquisite process of crystal
growth and mineralisation.13 14 The amelogenesis imperfecta
associated gene mutations identified to date involve two
enamel extracellular matrix molecules: amelogenin (OMIM
300391) and enamelin (OMIM 606585). Amelogenin, the
protein product of the AMELX Xq22 and AMELY Yp11, genes,
constitutes 90% of the organic matrix in developing enamel
and is considered to be critical for normal enamel thickness
and structure.15 Enamelin, the protein product of the ENAM
gene on chromosome 4q21, is present in comparatively small
amounts and undergoes a series of proteolytic cleavages to
generate several polypeptides that are thought to participate
in enamel crystal nucleation and extension, and the regula-
tion of crystal habit.16–18 Multiple allelic mutations in the
genes coding for amelogenin and enamelin are associated
with distinctly different amelogenesis imperfecta pheno-
types,6 7 suggesting that these proteins perform unique and
critical functions during enamel formation.
Besides ENAM and AMELX, a number of other genes critical
to enamel formation have been identified and proposed as
candidates for amelogenesis imperfecta, including amelo-
blastin (AMBN on 4q21; OMIM 601259),19 tuftelin, (TUFT1 on
chromosome 1q21; OMIM 600087),20 and two genes for
enamel related proteinases: enamelysin (MMP20 on 11q22-
q23; OMIM 604629) and kallikrein 4 (KLK4 on 19q13; OMIM
603767).21 22 These proteinases are believed to regulate the
enamel matrix protein processing that ultimately defines the
structure and composition of enamel.23 Abnormal proteolytic
processing of the enamel matrix proteins has been postulated
to be the principal developmental mechanism associated with
the autosomally inherited forms of hypomaturation amelo-
genesis imperfecta.8 Indeed, teeth from individuals with
autosomal recessive hypomaturation amelogenesis imper-
fecta show retention of amelogenin proteins supporting a
proteinase or protein processing defect.24 25 Mice lacking
normal MMP20 activity have hypoplastic and poorly miner-
alised enamel.26 To date there have been no human mutations
identified in MMP20 or KLK4.
Key points
N Serine proteases play critical roles in numerous
regulatory and developmental processes and are
expressed in most tissues. Only a few mutations in
serine proteinase genes have been identified to date.
N The serine protease superfamily is extremely diverse
and includes the kallikrein family (KLK genes clustered
on chromosome 19.13).
N We have identified the first mutation in the kallikrein
gene family, the KLK4 gene, and have shown this
mutation to be associated with autosomal recessive
hypomaturation amelogenesis imperfecta.
N The amelogenesis imperfectas are a clinically and
genetically heterogeneous group of disorders affecting
tooth enamel formation.
N The identified KLK4 gene mutation (g.2142G.A)
would result in a truncated kallikrein 4 protein that
lacks the S207 of the catalytic triad that is essential for
proteolytic activity in this serine proteinase.
N Abnormal kallikrein 4 activity causes the enamel
crystallites to grow incompletely in thickness or width
but to the normal length. This results in enamel that is of
normal thickness but is incompletely mineralised.
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In this report, we describe the first mutation in the KLK4
gene and its association with autosomal recessive hypo-
maturation amelogenesis imperfecta. These findings indi-
cate that kallikrein 4 plays a critical role in normal
enamel formation and provides additional evidence for
genetic heterogeneity for autosomal recessive amelogenesis
imperfecta.
MATERIALS AND METHODS
Family and phenotype analyses
This study was approved by the University of North Carolina
and the University of Pittsburgh Institutional Review Board.
All participants provided written consent prior to enrolment.
The family shown in fig 1A was ascertained from an affected
proband (II-1) who had generally yellow brown enamel
(fig 1B). All available family members were examined
clinically and radiographically to determine affected status
and to characterise the clinical phenotype.
Molecular studies
Genomic DNA was isolated from peripheral blood leucocytes
from the two affected siblings using the QIAamp blood kit
(Qiagen, Santa Clara, CA) as previously reported.27 All six
exons of KLK4 were amplified using the primers shown in
table 1. PCR was performed in a volume of 50 ml containing
0.6 mM each of forward and reverse primers, 0.2 mM dNTPs,
2.5 mM MgCl2, 16PCR buffer, 200 ng DNA, 1 unit of Taq
DNA polymerase and either 3 ml DMSO (exons 1, 5, and 6) or
3 ml PCR enhancer (exons 2, 3, and 4; Invitrogen, Carlsbad,
CA). PCR was performed by an initial denaturation at 95 C̊
for 1 min then 94 C̊ for 3 minutes, followed by 35 cycles of
denaturation at 94 C̊ for 35 s, annealing for 1 min at the
temperatures listed in table 1, extension at 72 C̊ for 1 min,
followed by a final extension at 72 C̊ for 10 min. PCR
products were electrophoresed through 1% agarose gels and
the amplicons extracted using the Qiagen gel extraction kit.
Extracted amplicons were sequenced using ABI Big Dye
terminator chemistry and an ABI 3730 DNA analyser. PCR
products were sequenced in both directions to minimise
sequencing artefacts.
RESULTS
The children were healthy with no evidence of abnormal
ectodermal tissues, or renal or ocular abnormalities, as have
been reported in association with syndromic cases of
abnormal enamel formation.28 29 One of the children (II-2)
was cognitively delayed while the proband (II-1) was
developmentally normal. Dental examination of the parents
showed no evidence of any enamel malformation. The
parents denied knowledge of consanguinity. The proband
had one sibling who was also affected with a nearly identical
dental phenotype (fig 1A). Both the primary and permanent
dentitions in the proband and sibling (ages 9 and 10 years)
were similarly affected showing a yellow brown discoloration
(fig 1B). The teeth were excessively sensitive to hot and cold,
making it painful to masticate. Radiographically the teeth
appeared morphologically normal in shape indicating that
the enamel was of normal thickness (fig 1C). The enamel
showed only a slightly increased opacity compared with the
dentin, indicative of a decreased enamel mineral content.
Enamel of the affected children had fractured from the
occlusal surfaces of the primary molars, which is consistent
with a decreased mineral content. One affected child (II-2)
had an anterior dental open bite while the other child (II-1)
did not.
The hypomaturation phenotype and apparent autosomal
recessive mode of inheritance observed in this family led us
to use a candidate gene approach and sequence the KLK4
gene directly. All six exons, including the intron-exon
boundaries, were sequenced. A total of three coding region
sequence alterations were found, all of which were homo-
zygous in both affected children (table 2). The synonymous
p.S100S (g.1984C.T; refSNP ID: rs198966) and non-synon-
ymous p.S22A (g.1327T.G; refSNP ID: rs1654551) single
nucleotide polymorphisms are known sequence alterations of
KLK4. The minor allele frequency of the g.1984C.T single
nucleotide polymorphism in 134 control African-American
chromosomes was 7%. The p.W153X mutation (fig 2B) is
predicted to be causative in the siblings. This nonsense
mutation occurs at a tryptophan residue that is completely
conserved across KLK4 proteins in mouse and pig, and across
all 15 human kallikrein proteins.30 The resultant truncated
protein would lack the final 101 amino acids, including
several functionally important and highly conserved
domains, including the S207 of the catalytic triad
(figure 2B). This sequence alteration was not found in the
134 African-American control chromosomes tested.
Figure 1 The family pedigree (A) had two affected female children
born to two unaffected adults. The dentition of both affected children was
normal in morphology but had a generally yellow brown colour (B) that
affected both the primary and permanent teeth. Panographic
radiography (C) revealed worn and fractured enamel on the posterior
teeth and enamel that had a reduced opacity that was only slightly
greater than the underlying dentin (arrows), indicative of enamel
hypomineralisation.
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DISCUSSION
Kallikrein 4, initially called enamel matrix serine proteinase,
was originally isolated from developing porcine enamel and
thought to be expressed only in developing teeth.22 Human
KLK4maps to chromosome 19q13.4, a region that contains 15
tissue kallikrein genes.28 Subsequently several groups inde-
pendently isolated the human KLK4 gene and cDNA
sequences from prostate and a variety of other tissues,
including testis, breast, colon, thyroid, uterus, and central
nervous system tissue.31–33 Recently, KLK4 has been shown to
be expressed in skin.1 The specific function of the kallikrein 4
proteinase in these different tissues is not known.
During enamel formation kallikrein 4 is known to be
secreted by both odontoblasts that form the dentin and
ameloblasts that form the enamel.22 34 Kallikrein 4 is thought
to be the predominant enzyme that degrades enamel proteins
during the maturation stage of development, and has been
shown to cleave amelogenin (the most abundant enamel
protein).35 36 Kallikrein 4 is secreted as an inactive zymogen of
230 amino acids that can be activated by MMP20 through the
removal of a 6 amino acid propeptide.35 The characteristic
triad of catalytic amino acids (H71, D116, and S207) is
conserved between species and believed to be critical to its
proteolytic function.1 The human KLK4 gene consists of six
exons, five of which are coding.37
The enamel phenotype observed in this family is consistent
with a loss of kallikrein 4 function and its purported role in
enamel mineralisation as well as its known temporal and
spatial pattern of expression. The transcript produced by the
g.2142G.A mutation would result in a 153 amino acid
protein that lacks the S207 of the catalytic triad that is
essential for proteolytic activity (fig 2B). The truncated
Table 1 Primers to amplify KLK4
Exon Sequence Annealing temperature, C̊ Product size, bp
1 F 59- TGGAAGTTTGCAGCACCTGA –39 62 227
R 59- GCGACATGGAGCTGTAGGGA –39
2 F 59- CTCATCCCCAGGTGCTGACGT –39 58 222
R 59- GCCATGGGGGACGGATAACA –39
3 and 4 F 59- GCCCCCAGCCCTGACTCG –39 62 1195
R 59-TCACGCACTGCAGCACGGTA –39
5 F 59- GAGGTCCTCTGCCCAGTCG –39 58 550
R 59-ATTGGTAAGGCTCCCCGTCA –39
6 (set 1) F 59- TATGTCGCTGGGCTATGTTG-39 58 281
R 59- GGCCTGGACGGTTTTCTC-39
6 (set 2) F 59- TGGCGTGCCAGGTGTCTA –39 62 761
R 59- ATGGAAGGGGAAGCAAGGAG –39
Figure 2 Mutational analysis of KLK4. A. Portion of exon 4 sequenced with the reverse primer shown in table 1. 1) Wild-type sequence. 2) Sequence
from an affected individual showing the nonsense mutation (g.2142G.A; C.T on reverse sequence). B. Predicted effect of mutation on the kallikrein 4
protein. The top is a portion of the 254 amino acid wild-type protein. The middle is a normal splice variant that lacks exon 4, resulting in premature
termination and a truncated protein of 159 amino acids. The bottom is the consequence of the mutation which results in a truncated protein of 152
amino acids.
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product would also lack the conserved asparagine and glycine
encoded by exon 6 that characterise the binding pocket that
defines substrate specificity.1 The loss of the S207 site as well
as the binding pocket makes it unlikely that the mutant
protein (p.W153X) would be functional and process the
enamel matrix proteins in a kinetically normal manner.
During enamel formation MMP20 is expressed predomi-
nantly during the secretory and transitional stages and is
believed to be responsible for the early and essential
processing of amelogenin.38 39 During this time much of the
enamel matrix is removed and the enamel crystallites grow to
achieve approximately 40–60% mineral per volume.40 41 The
loss of kallikrein 4 function would primarily interfere with
the maturation stage of enamel development when it is
maximally expressed.36 Previous studies have shown that
autosomal recessive hypomaturation amelogenesis imper-
fecta teeth have a marked retention of enamel matrix
proteins and amelogenin resulting in a dramatic reduction
of mineral content.24 42 The clinical phenotype characterised
by enamel loss and a marked reduction in radiographic
enamel opacity is consistent with the enamel being hypo-
mineralised similar to cases we have previously reported (no
teeth were available from this family for analysis). The
enamel in the affected individuals had a normal enamel
thickness indicating that the enamel matrix was secreted in a
relatively normal amount and, although the enamel appeared
radiographically hypomineralised, it was mineralised to a
greater extent than the dentin (dentin is normally 55–60%
mineral per volume). Collectively, this indicates that the
enamel crystallites grew to a normal length producing
enamel of normal thickness, however the crystallites failed
to grow completely in their thickness or width, probably
because of retention of enamel proteins, thereby producing a
hypomineralised enamel. Taken together, these findings
indicate that a loss of kallikrein 4 function primarily affected
the maturation stage of enamel development and resulted in
the enamel crystallites not achieving the final growth that
would have allowed the final deposition of an additional 15–
20% mineral.
Interestingly, an alternative splice product lacking exon 6
(the fifth coding exon) is the predominant kallikrein 4
transcript in skin and has also been described in human
endometrial tumour cultures.1 43 This alternative splice
product would result in a truncated protein of 159 amino
acids that would lack the catalytic S207 and the binding
pocket that defines substrate specificity and is therefore not
expected to encode a protein with proteolytic activity.32 36 At
this time, the role of the alternative splice product is not
known. The protein encoded by this natural splice variant is
very similar to the protein encoded by the g.2142G.A
mutation (fig 2B). The limitation of the phenotype to enamel
in the affected individuals in this family suggests that
kallikrein 4 may have distinctly different functions or
redundancies in different tissues. Splice variants as discussed
above could potentially have functionality in some tissues but
not others. The focused phenotype may also be explained by
there being limited kallikrein genes expressed in developing
enamel (only kallikrein 4 has been localised to enamel),
while all other tissues studied have been shown to express
multiple kallikrein genes (for example, skin expresses KLK1,
KLK4, KLK5, KLK6, KLK7, KLK8, KLK11, and KLK13).32
The rarity of autosomal recessive hypomaturation amelo-
genesis imperfecta in the population suggests that mutations
in the KLK4 gene are not common.5 The finding that the
affected individuals were homozygous for the g.2142G.A
mutation raises the possibilities of consanguinity, a founder
effect, or a mutational hotspot in KLK4. Given that all coding
region sequence alterations (table 2) were homozygous in the
affected individuals, these results would argue against a
mutational hotspot and for alleles inherited identical by
descent.
In summary, the g.2142G.A mutation is the first mutation
reported in the human KLK4 gene and represents the first
mutation found to cause autosomal recessive hypomatura-
tion amelogenesis imperfecta. This is the first mutation in a
proteinase involved in enamel matrix processing and
substantiates the previous hypothesis of Witkop and Sauk
that a protease defect could underlie autosomal recessive
pigmented hypomaturation amelogenesis imperfecta.5 These
results also indicate that normal kallikrein 4 function is
critical for enamel mineralisation. Mutations in three genes
(KLK4, ENAM, and AMELX) have now been demonstrated to
result in amelogenesis imperfecta. Continued mutational
analysis of families with amelogenesis imperfecta will allow a
comprehensive standardised nomenclature system to be
developed for this group of disorders that will include
molecular delineation as well as mode of inheritance and
phenotype.
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